Increase understanding about lifesaving plasma protein
therapies and rare diseases
Patient organizations representing users of plasma protein
therapies have pledged their support and are working to promote the event via websites, newsletters, social media, and outreach.
In the placebo group, plasma protein
concentrations increased at 80% of V'O2max IE and 30M, returning to pre-exercise concentrations by 30H (P < 0.
Pregnancy-associated plasma protein
A as a marker of acute coronary syndromes.
The 10 most abundant proteins--which include antibodies, the iron transporter called transferrin, and fibrinogen--account for more than 90 percent of all plasma protein
Researchers concluded that in healthy adults, 10 ml CGJ increased serum antioxidant capacity and protected LDL against oxidation to an extent similar to that obtained with 400 IU alpha-tocophe rol/d but decreased native plasma protein
oxidation significantly more than did alpha-tocopherol.
Linking a therapeutic plasma protein
with albumin may provide a number of product advantages, including the possibility of a longer acting form of the molecule for use in the human body, through extended circulating half life and consistent maintenance of therapeutic levels of the drug.
Represent people who use plasma protein
therapies to treat coagulation disorders, immune deficiencies, genetic emphysema or other conditions; and
PPTA applauds Congresswoman Matsui for her continued support of the plasma protein
therapeutics industry and its patients.
In addition, patient organizations representing individuals who rely on plasma protein
therapies that treat rare diseases have pledged their support.
A number of issues were identified, including genetic variation of plasma proteins
, liquid-phase multidimensional separation schemes compared with gel-based separation methods, parameters for high throughput links to mass spectrometry (MS), removal of high abundance proteins, and use of antibody arrays or multiplexed enzyme-linked immunosorbent assays (ELISAs) for plasma protein
8, 2014 /PRNewswire/ -- The Plasma Protein
Therapeutics Association(PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 12-18 designed to: